This Philadelphia Phillies report inparticular covers IBM s

This explains 2008 world series baseball report inparticular, philadelphia phillies tells covers IBM's email archiving solution, Content Collector. Itevaluates IBM Content Collector across 85 technical criteria, profiles thevendor and concludes with a detailed assessment of the solution's overallstrengths and weaknesses versus those of the other vendors that were included aspart of the assessment (i.e. Mimosa NearPoint, Autonomy EAS, Symantec EnterpriseVault, and CA Message Manager). The report also provides a technical comparisonmatrix that evaluates the capabilities of each of the five vendors' emailarchiving solutions based on a five metric scale (i.e No Support up toExtensive Support).

Who should read: This report is a must have resource for those seeking toevaluate select email archiving solutions and ultimately create a short list ofsuitable candidates for further analysis autographed baseball . The report also provides addedperspective for those companies that are actively involved in the emailarchiving sector and wish to better understand the competition's technicalcapabilities and related positioning philadelphiaphillies . MARTINSRIED, GERMANY, Jul 23 (MARKET WIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) will publish itsfirst six months' 2009 results on July 29, 2009 at 7:00 a.m CET.At 2:00 p.m CET (1:00 p.m GMT, 8:00 a.m philies cap . EDT), the Management Board ofMorphoSys AG will host a public conference call to present MorphoSys'sfinancial results for the first six months of 2009 and provide furtherdetails on the Company's latest developments.Dial-in numbers (listen only):Germany: +49 (0) 69 71049 1462United Kingdom:+44 (0) 1212 604 860USA: +1(1) 866 347 1957An audio replay and manuscripts of the conference will be availableon in the afternoon of the same day.For further information please contact: Dr philies hat .

Claudia Gutjahr-Loeser, Headof Corporate Communications & Investor Relations, Tel: +49 (0) 89 / 89927-122, or Mario Brkulj, Senior ManagerCorporate Communications & Investor Relations, Tel: +49 (0) 89 / 89927-454, About MorphoSys:MorphoSys is a publicly traded biotechnology company focused on thegeneration of fully human antibodies as a means to discover and developinnovative antibody-based drugs against life-threatening diseases.MorphoSys's goal is to establish HuCAL as the technology of choice forantibody generation in research, diagnostics and therapeuticapplications baseball tickets . The Company currently has therapeutic and researchalliances with the majority of the world's largest pharmaceuticalcompanies including Boehringer Ingelheim, Centocor Ortho BiotechInc./Johnson & Johnson, Novartis, Pfizer and Roche philies hats . Within thesepartnerships, more than 50 therapeutic antibody programs are ongoing inwhich MorphoSys participates through exclusive license and milestonespayments as well as royalties on any end products ryan howard . Additionally,MorphoSys is active in the antibody research market through its AbDSerotec business unit world series 2008 . The business unit has operations in Germany(Munich), the U.S (Raleigh, NC) and U.K (Oxford).

For furtherinformation please visit http://(R), HuCAL GOLD(R), HuCAL PLATINUM(R) and RapMAT(R) are registeredtrademarks of MorphoSys AGThis communication contains certain forward-looking statements concerningthe MorphoSys group of companies cole hamels bio . The forward-looking statementscontained herein represent the judgment of MorphoSys as of the date ofthis release and involve risks and uncertainties philadelphia phillies . Should actualconditions differ from the Company's assumptions, actual results andactions may differ from those anticipated philadelphiaphillies . MorphoSys does not intend toupdate any of these forward-looking statements as far as the wording ofthe relevant press release is concerned This announcement wasoriginally distributed by Hugin philies cap . The issuer is solely responsible for thecontent of this announcement.Press Release: Copyright Hugin AS 2009. All rights reserved.Copyright 2009, Market Wire, All rights reserved.-0-.

New Data show 274% Growth since 2007WASHINGTON, July 23 /PRNewswire-USNewswire/ -- E-Verify is now being used todetermine work authorization for 1 in 4 new hires nationwide according tonumbers released to the Center for Immigration Studies by the Department ofHomeland Security on July 4, 2009 cole hamels jerseys . This increase has occurred even though theE-Verify program remains voluntary at the federal level, with only 12 statesrequiring its use in some manner by employers philies hat . The report containing thesenumbers is at 2007, when E-Verify took its current form, it was used to screen 1 in 19new hires nationwide philies hats . The new figures represent a 274 percent increase, ifusage remains steady for the remainder of this year . The number of queries sofar in 2009 is about 6 million, nearly what they were for all of 2008 andtwice that for 2007. If the current rate of use continues, E-Verify will bequeried nearly 12.3 million times this year.E-Verify is being used at 511,228 worksites, up from the 400,000 reported bythe Department of Homeland Security in January 2009.A total of 134,702employers have signed up to use the program. The industry sectors most usingE-Verify are in the "professional, scientific and technical arena" with 72,946employers signed up, more than twice as many as any other industry sector.Down at 20th in ranking are construction firms, at 7,959 employers using thesystem.E-Verify enables cheap, efficient, and accurate compliance with the federalban on hiring illegal aliens.